315
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor: BiGART 2023 Issue

Prediction of dose-sparing by protons assessed by a knowledge-based planning tool in radiotherapy of brain tumours

, ORCID Icon, , , , , , , ORCID Icon, & ORCID Icon show all
Pages 1541-1545 | Received 22 May 2023, Accepted 22 Sep 2023, Published online: 04 Oct 2023

References

  • Shih HA, Sherman JC, Nachtigall LB, et al. Proton therapy for low-grade gliomas: results from a prospective trial. Cancer. 2015;121(10):1712–1719. doi: 10.1002/cncr.29237.
  • Noel G, Gondi V. Proton therapy for tumors of the base of the skull. Chin Clin Oncol. 2016;5:1–17.
  • Noël G, Habrand JL, Mammar H, et al. Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Protonthérapie d’Orsay. Strahlenther Onkol. 2002;178:480–485.
  • Sherman JC, Colvin MK, Mancuso SM, et al. Neurocognitive effects of proton radiation therapy in adults with low-grade glioma. J Neurooncol. 2016;126(1):157–164. doi: 10.1007/s11060-015-1952-5.
  • Thurin E, Nyström PW, Smits A, et al. Proton therapy for low-grade gliomas in adults: a systematic review. Clin Neurol Neurosurg. 2018;174:233–238. doi: 10.1016/j.clineuro.2018.08.003.
  • van der Weide HL, Kramer MCA, Scandurra D, et al. Proton therapy for selected low grade glioma patients in The Netherlands. Radiother Oncol. 2021;154:283–290. doi: 10.1016/j.radonc.2020.11.004.
  • Grau C, Durante M, Georg D, et al. Particle therapy in Europe. Mol Oncol. 2020;14(7):1492–1499. doi: 10.1002/1878-0261.12677.
  • Willson R. Radiological use of fast protons. Radiology. 1946;47:487–491.
  • Durante M, Paganetti H. Nuclear physics in particle therapy: a review. Rep Prog Phys. 2016;79:096702.
  • DNOG. DNOG 2018 Nationale retningslinjer for proton behandeling [National guidelines for proton therapy]; 2018. Available from: https://www.dnog.dk/assets/files/Retningslinier PDF/DNOG 2018 Proton retningslinjer.pdf
  • Smulders B, Alshaikhi J, Stolarczyk L, et al. Proceedings to the 60th Annual Conference of the Particle Therapy Cooperative Group. Int J Part Ther. 2023;9(4):306–470.
  • DNOG. Retningslinjer for stralebehandling [Guidelines for radiotherapy]; 2016. p. 1–16. Available from: https://dnog.dk/onewebmedia/files/Retningslinier PDF/DNOG 2016 Retningslinjer for straalebehandling final.pdf
  • Combs SE, Baumert BG, Bendszus M, et al. ESTRO ACROP guideline for target volume delineation of skull base tumors. Radiother Oncol. 2021;156:80–94. doi: 10.1016/j.radonc.2020.11.014.
  • Eekers DB, In 't Ven L, Roelofs E, et al. The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology. Radiother Oncol. 2018;128(1):37–43. doi: 10.1016/j.radonc.2017.12.013.
  • Toma-Dasu I, Dasu A, Vestergaard A, et al. RBE for proton radiation therapy – a Nordic view in the international perspective. Acta Oncol. 2020;59(10):1151–1156. doi: 10.1080/0284186X.2020.1826573.
  • Tol JP, Delaney AR, Dahele M, et al. Evaluation of a knowledge-based planning solution for head and neck cancer. Int J Radiat Oncol Biol Phys. 2015;91(3):612–620. doi: 10.1016/j.ijrobp.2014.11.014.
  • Xu Y, Cyriac J, De Ornelas M, et al. Knowledge-based planning for robustly optimized intensity-modulated proton therapy of head and neck cancer patients. Front Oncol. 2021;11:737901. doi: 10.3389/fonc.2021.737901.
  • Xu Y, Brovold N, Cyriac J, et al. Assessment of knowledge-based planning for prostate intensity modulated proton therapy. Int J Part Ther. 2021;8(2):62–72. doi: 10.14338/IJPT-20-00088.1.
  • Chatterjee A, Serban M, Abdulkarim B, et al. Performance of knowledge-based radiation therapy planning for the glioblastoma disease site. Int J Radiat Oncol Biol Phys. 2017;99(4):1021–1028. doi: 10.1016/j.ijrobp.2017.07.012.
  • Delaney AR, Verbakel WF, Lindberg J, et al. Evaluation of an automated proton planning solution. Cureus. 2018;10(12):e3696. doi: 10.7759/cureus.3696.
  • Delaney AR, Dahele M, Tol JP, et al. Using a knowledge-based planning solution to select patients for proton therapy. Radiother Oncol. 2017;124(2):263–270. doi: 10.1016/j.radonc.2017.03.020.
  • Tol JP, Dahele M, Gregoire V, et al. Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance. Radiother Oncol. 2019;130:75–81. doi: 10.1016/j.radonc.2018.10.005.
  • Lühr A, von Neubeck C, Pawelke J, et al. “Radiobiology of proton therapy”: results of an International Expert Workshop. Radiother Oncol. 2018;128(1):56–67. doi: 10.1016/j.radonc.2018.05.018.
  • Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59(22):R419–R472. doi: 10.1088/0031-9155/59/22/R419.
  • Giovannini G, Böhlen T, Cabal G, et al. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios. Radiat Oncol. 2016;11(1):68. doi: 10.1186/s13014-016-0642-6.
  • Schreuder AN, Hedrick SG, Renegar JR, et al. Review of proton radiation therapy and the path to widespread clinical adoption. Med Phys Int J. 2016;4:35–46.
  • Ödén J, Toma-Dasu I, Witt Nyström P, et al. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors. Med Phys. 2020;47(2):342–351. doi: 10.1002/mp.13911.
  • Peeler CR, Mirkovic D, Titt U, et al. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016;121(3):395–401. doi: 10.1016/j.radonc.2016.11.001.
  • Jones B, McMahon SJ, Prise KM. The radiobiology of proton therapy: challenges and opportunities around relative biological effectiveness. Clin Oncol (R Coll Radiol). 2018;30(5):285–292. doi: 10.1016/j.clon.2018.01.010.
  • Niemierko A, Schuemann J, Niyazi M, et al. Brain necrosis in adult patients after proton therapy: is there evidence for dependency on linear energy transfer? Int J Radiat Oncol Biol Phys. 2021;109(1):109–119. doi: 10.1016/j.ijrobp.2020.08.058.
  • Feng CH, Cornell M, Moore KL, et al. Automated contouring and planning pipeline for hippocampal-avoidant whole-brain radiotherapy. Radiat Oncol. 2020;15(1):251. doi: 10.1186/s13014-020-01689-y.
  • Liu H, Clark R, Magliari A, et al. RapidPlan hippocampal sparing whole brain model version 2—how far can we reduce the dose? Med Dosim. 2022;47(3):258–263. doi: 10.1016/j.meddos.2022.04.003.
  • Rusu I, Roeske J, Solanki A, et al. Fully automated planning and delivery of hippocampal-sparing whole brain irradiation. Med Dosim. 2022;47(1):8–13. doi: 10.1016/j.meddos.2021.06.004.
  • Sagawa T, Ueda Y, Tsuru H, et al. Dosimetric potential of knowledge-based planning model trained with HyperArc plans for brain metastases. J Appl Clin Med Phys. 2023;24:1–10.
  • O'Toole J, Picton M, Perez M, et al. Improving efficiency in the radiation management of multiple brain metastases using a knowledge-based planning solution for single-isocentre volumetric modulated arc therapy (VMAT) technique. J Med Radiat Sci. 2021;68(4):364–370. doi: 10.1002/jmrs.526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.